Cannara Biotech's total assets for Q3 2025 were C$170.09M, an increase of 5.38% from the previous quarter. TSE:LOVE total liabilities were C$71.49M for the fiscal quarter, a 6.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.